[go: up one dir, main page]

WO2013083753A3 - Identification d'un virus porcin de type paréchovirus et applications - Google Patents

Identification d'un virus porcin de type paréchovirus et applications Download PDF

Info

Publication number
WO2013083753A3
WO2013083753A3 PCT/EP2012/074741 EP2012074741W WO2013083753A3 WO 2013083753 A3 WO2013083753 A3 WO 2013083753A3 EP 2012074741 W EP2012074741 W EP 2012074741W WO 2013083753 A3 WO2013083753 A3 WO 2013083753A3
Authority
WO
WIPO (PCT)
Prior art keywords
swine
virus
parecho
identification
applications
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2012/074741
Other languages
English (en)
Other versions
WO2013083753A2 (fr
Inventor
Marc Eloit
Justine Cheval
Virginie Sauvage
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ecole Nationale Veterinaire dAlfort
PATHOQUEST
Institut Pasteur
Original Assignee
Ecole Nationale Veterinaire dAlfort
PATHOQUEST
Institut Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ecole Nationale Veterinaire dAlfort, PATHOQUEST, Institut Pasteur filed Critical Ecole Nationale Veterinaire dAlfort
Priority to EP12797926.8A priority Critical patent/EP2788477A2/fr
Publication of WO2013083753A2 publication Critical patent/WO2013083753A2/fr
Publication of WO2013083753A3 publication Critical patent/WO2013083753A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32511—Parechovirus, e.g. human parechovirus
    • C12N2770/32521—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32511—Parechovirus, e.g. human parechovirus
    • C12N2770/32522—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32511—Parechovirus, e.g. human parechovirus
    • C12N2770/32534—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La présente invention concerne le SPe LV, un virus de type paréchovirus porcin apparenté au virus Ljungan (LV) et au paréchovirus humain (HPeV). La présente invention concerne en outre de nouvelles protéines codées par le SPeLV, qui présentent une certaine homologie avec les protéines de capside du LV et du HPeV. La présente invention concerne en outre des procédés destinés à monter une réponse immunitaire contre le SPeLV chez un sujet.
PCT/EP2012/074741 2011-12-07 2012-12-07 Identification d'un virus porcin de type paréchovirus et applications Ceased WO2013083753A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP12797926.8A EP2788477A2 (fr) 2011-12-07 2012-12-07 Identification d'un virus porcin de type paréchovirus et applications

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161567904P 2011-12-07 2011-12-07
US61/567,904 2011-12-07

Publications (2)

Publication Number Publication Date
WO2013083753A2 WO2013083753A2 (fr) 2013-06-13
WO2013083753A3 true WO2013083753A3 (fr) 2013-08-15

Family

ID=47297291

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2012/074741 Ceased WO2013083753A2 (fr) 2011-12-07 2012-12-07 Identification d'un virus porcin de type paréchovirus et applications

Country Status (2)

Country Link
EP (1) EP2788477A2 (fr)
WO (1) WO2013083753A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2020000495A (es) * 2017-07-14 2020-08-20 Oncorus Inc Polinucleotidos encapsulados y metodos de uso.

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003019197A2 (fr) * 2001-08-22 2003-03-06 Apodemus Ab Modele diabetique
WO2010084324A1 (fr) * 2009-01-22 2010-07-29 Apodemus Ab Virus de ljungan présentant des caractéristiques de réplication améliorées

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5422A (en) 1848-02-01 Spark-arrester
US109A (en) 1836-12-15 Erawijtg
US4603112A (en) 1981-12-24 1986-07-29 Health Research, Incorporated Modified vaccinia virus
US4769330A (en) 1981-12-24 1988-09-06 Health Research, Incorporated Modified vaccinia virus and methods for making and using the same
DE3642912A1 (de) 1986-12-16 1988-06-30 Leybold Ag Messeinrichtung fuer paramagnetische messgeraete mit einer messkammer
HU212924B (en) 1989-05-25 1996-12-30 Chiron Corp Adjuvant formulation comprising a submicron oil droplet emulsion
FR2649013B1 (fr) 1989-07-03 1991-10-25 Seppic Sa Vaccins et vecteurs de principes actifs fluides contenant une huile metabolisable
FR2649012B1 (fr) 1989-07-03 1991-10-25 Seppic Sa Emulsions multiphasiques injectables
US5100587A (en) 1989-11-13 1992-03-31 The United States Of America As Represented By The Department Of Energy Solid-state radioluminescent zeolite-containing composition and light sources
AU672359B2 (en) 1991-03-07 1996-10-03 Virogenetics Corporation Genetically engineered vaccine strain
US5756102A (en) 1990-11-20 1998-05-26 Virogenetics Corporation Poxvirus-canine distemper virus (CDV) recombinants and compositions and methods employing the recombinants
US5179993A (en) 1991-03-26 1993-01-19 Hughes Aircraft Company Method of fabricating anisometric metal needles and birefringent suspension thereof in dielectric fluid
GB9326253D0 (en) 1993-12-23 1994-02-23 Smithkline Beecham Biolog Vaccines
FR2738842B1 (fr) 1995-09-15 1997-10-31 Rhone Poulenc Rorer Sa Molecule d'adn circulaire a origine de replication conditionnelle, leur procede de preparation et leur utilisation en therapie genique
GB9711990D0 (en) 1997-06-11 1997-08-06 Smithkline Beecham Biolog Vaccine
GB9718901D0 (en) 1997-09-05 1997-11-12 Smithkline Beecham Biolog Vaccine
DE69838992T2 (de) 1997-09-05 2008-12-24 Glaxosmithkline Biologicals S.A., Rixensart Öl-in-Wasser Emulsionen mit Saponinen
FR2777909B1 (fr) 1998-04-24 2002-08-02 Pasteur Institut Utilisation de sequences d'adn de structure triplex pour le tranfert de sequences de nucleotides dans des cellules, vecteurs recombinants contenant ces sequences triplex
FR2791895B1 (fr) 1999-03-23 2001-06-15 Pasteur Merieux Serums Vacc Utilisation de trehalose pour stabiliser un vaccin liquide
HK1050210B (en) 1999-10-12 2007-08-24 Institut Pasteur Lentiviral triplex dna, and vectors and recombinant cells containing lentiviral triplex dna
WO2009019612A2 (fr) 2007-08-03 2009-02-12 Institut Pasteur Vecteurs de transfert de gènes antiviraux et leurs applications médicinales
FR2920158B1 (fr) 2007-08-24 2010-03-12 Centre Nat Rech Scient Production de plasmides et expression de proteines recombinantes dans des cellules cultivees sans antibiotiques

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003019197A2 (fr) * 2001-08-22 2003-03-06 Apodemus Ab Modele diabetique
WO2010084324A1 (fr) * 2009-01-22 2010-07-29 Apodemus Ab Virus de ljungan présentant des caractéristiques de réplication améliorées

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
BENSCHOP K ET AL: "Detection of human enterovirus and human parechovirus (HPeV) genotypes from clinical stool samples: polymerase chain reaction and direct molecular typing, culture characteristics, and serotyping", DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASES, vol. 68, no. 2, 1 October 2010 (2010-10-01), pages 166 - 173, XP027286309, ISSN: 0732-8893, [retrieved on 20100914] *
DATABASE EMBL [Online] 22 July 2005 (2005-07-22), Uenishi H. et al.: "Sus scrofa mRNA, clone:ITT010080H08, 5' end, expressed in intestine", XP002699029, Database accession no. BW983151 *
DATABASE EMBL [online] 22 July 2012 (2012-07-22), Database accession no. EM_STD:JQ316470 *
G. TAPIA ET AL: "No Ljungan Virus RNA in Stool Samples From the Norwegian Environmental Triggers of Type 1 Diabetes (MIDIA) Cohort Study", DIABETES CARE, vol. 33, no. 5, 1 May 2010 (2010-05-01), pages 1069 - 1071, XP055067026, ISSN: 0149-5992, DOI: 10.2337/dc09-1951 *
GERMAN TAPIA ET AL: "Longitudinal study of parechovirus infection in infancy and risk of repeated positivity for multiple islet autoantibodies: the MIDIA study", PEDIATRIC DIABETES, vol. 12, no. 1, 12 February 2011 (2011-02-12), pages 58 - 62, XP055066392, ISSN: 1399-543X, DOI: 10.1111/j.1399-5448.2010.00658.x *
V. SAUVAGE ET AL: "A Member of a New Picornaviridae Genus Is Shed in Pig Feces", JOURNAL OF VIROLOGY, vol. 86, no. 18, 15 September 2012 (2012-09-15), pages 10036 - 10046, XP055066340, ISSN: 0022-538X, DOI: 10.1128/JVI.00046-12 *

Also Published As

Publication number Publication date
EP2788477A2 (fr) 2014-10-15
WO2013083753A2 (fr) 2013-06-13

Similar Documents

Publication Publication Date Title
CY1123208T1 (el) Κυκλικα παραγωγα εστερων βορονικου οξεος, μεθοδος για την παρασκευη και θεραπευτικες χρησεις αυτων
MY158992A (en) Forms of rifaximin and uses thereof
EA201890942A1 (ru) Мультивалентные вакцины с синтетическими наноносителями
MX2013008390A (es) Preparacion de estructuras de metal-triazolato.
EP4223770A3 (fr) Nouvelles molécules de fusion et leurs utilisations
WO2013106834A3 (fr) Peptides wt-1 immunogènes et leurs procédés d'utilisation
ZA201404625B (en) Polycyclic derivatives, preparation method and medical uses thereof
TR201905619T4 (tr) Alerji aşısı olarak peptit taşıyıcı füzyon proteinleri.
PH12015501101A1 (en) Method for eliciting an immune response to an immunogen
MX2021013109A (es) Proceso de preparacion de una vacuna tetravalente atenuada contra el virus del dengue.
IN2014CN04071A (fr)
WO2012047267A3 (fr) Immunogène polyvalent
BR112015008824A2 (pt) linhagens melhoradas de microalgas e processo das mesmas
IN2015DN02335A (fr)
MX357675B (es) Anticuerpos anti-jagged y métodos de uso.
GB2502390B (en) Novel Ni complex and its derivatives, producing method, and the use thereof as antioxidant
EA033027B1 (ru) Ослабленные вакцины от свиного гриппа и способы их получения и применения
WO2015095240A3 (fr) Biosynthèse de 1-undécène et d'oléfines terminales associées
IN2015DN00085A (fr)
AU2012248013B2 (en) Intermediate for synthesizing caspofungin and preparation method therefor
WO2013083753A3 (fr) Identification d'un virus porcin de type paréchovirus et applications
IL234492A (en) Crystalline forms of 5α - androstane - 3 β, 56β, - triol and methods for their preparation
WO2010110931A3 (fr) Vaccins glycoconjugués
PT2863766T (pt) Artigo de vestuário para melhorar a estimulação mecânica do tecido conjuntivo
WO2013095994A3 (fr) Micro-émulsions de parfum aqueuses transparentes

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12797926

Country of ref document: EP

Kind code of ref document: A2

DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2012797926

Country of ref document: EP

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12797926

Country of ref document: EP

Kind code of ref document: A2